Additional Metadata
Persistent URL dx.doi.org/10.1038/s41375-018-0024-1, hdl.handle.net/1765/104934
Journal Leukemia
Citation
Bringhen, S, Mina, R, Cafro, A.M. (Anna Maria), Liberati, A.M, Spada, S. (Stefano), Belotti, A. (Angelo), … Boccadoro, M. (2018). Once-weekly carfilzomib, pomalidomide, and low-dose dexamethasone for relapsed/refractory myeloma: a phase I/II study. Leukemia, 1–4. doi:10.1038/s41375-018-0024-1